CoChat

The DOI matches its Crossref record; 22 of the 24 references it cites were found in a registry or an index.

Abrogation of α-synuclein–mediated dopaminergic neurodegeneration in LRRK2-deficient rats

Open access
Daher, João P. L., Volpicelli-Daley, Laura A., Blackburn, Jonathan P., Moehle, Mark S., West, Andrew B. · 2014 · Proceedings of the National Academy of Sciences

Abstract

Significance: Mutations in the leucine-rich repeat kinase 2 ( LRRK2 ) gene are the most common known genetic cause of late-onset Parkinson disease, but the mechanisms underlying LRRK2 action in neurodegeneration are not clear. We demonstrate that rats deficient in LRRK2 expression are protected from dopaminergic neurodegeneration caused by overexpression of α-synuclein or exposure to LPS. LRRK2 expression is induced in proinflammatory brain myeloid cells under pathological conditions. Our results suggest that LRRK2 inhibition may have important neuroprotective effects by critically modulating neuroinflammatory responses. LRRK2 inhibition may therefore be a potentially efficacious approach to slow or stop the progression of brain disorders where myeloid cell activation drives aspects of dysfunction.

Overview

Integrity signals

Registry

Crossref · 10.1073/pnas.1403215111

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 24 references

Research works printed but not linked: 1

  1. 10.1371/journal.pgen.1001195 · DOI

Cited by

See all 223

Metadata

Authors
Daher, J. P. L., Volpicelli-Daley, L. A., Blackburn, J. P., Moehle, M. S., & West, A. B.
Affiliations
  • University of Alabama at Birmingham (US)
  • Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL 35294
Venue
Proceedings of the National Academy of Sciences
Published
2014-06-09
Volume
111
Issue
25
Pages
9289-9294
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2053206193
Cited by
223
References
24
Citations by year
2026: 6 · 2025: 15 · 2024: 9 · 2023: 19 · 2022: 18 · 2021: 26 · 2020: 24 · 2019: 17 · 2018: 28 · 2017: 19 · 2016: 17 · 2015: 18 · 2014: 7
FWCI
13.25
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Neurological Disorders and Stroke (F31NS081963, R01NS064934)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Keywords
LRRK2, alpha-synuclein, Parkinson's disease, dopaminergic neuron loss, neuroinflammation, myeloid cells, substantia nigra, lipopolysaccharide, inducible nitric oxide synthase, neuroprotection, AAV gene delivery
MeSH terms
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Animals, Humans, Lipopolysaccharides, Substantia Nigra, Protein Serine-Threonine Kinases, Neurodegenerative Diseases, Myeloid Cells, Rats, alpha-Synuclein, Nitric Oxide Synthase Type II, Rats, Transgenic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Abrogation of α-synuclein–mediated dopaminergic neurodegeneration in LRRK2-deficient rats. https://app.cochat.ai/papers/10.1073/pnas.1403215111
The paper
Daher, J. P. L., Volpicelli-Daley, L. A., Blackburn, J. P., Moehle, M. S., & West, A. B. (2014). Abrogation of α-synuclein–mediated dopaminergic neurodegeneration in LRRK2-deficient rats. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1403215111

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.